Daniela Pfister

Daniela Pfister is the Associate Director of Global Regulatory Affairs CMC Biosimilars at Sandoz, where they currently lead biosimilar regulatory projects and due diligence efforts. Previously, Daniela held key roles at Novartis, including Senior Regulatory CMC Manager, and played a significant role in the successful FDA and EMA approvals of Hyrimoz. They also contributed to the research and development of therapeutic antibodies as a Lead Scientist at MorphoSys and served as a Project Research Scientist at Leopold-Franzens Universität Innsbruck, where they focused on developmental and molecular biology. Daniela earned a PhD in Molecular Biology from Leopold-Franzens Universität Innsbruck.